期刊文献+

急性脑梗死患者血管介入治疗后纤溶活性变化的初步观察 被引量:6

下载PDF
导出
摘要 目的初步探索脑血管球囊成形支架置入术(PTAS)联合抗凝及抗血小板治疗对急性动脉粥样硬化性脑梗死患者体内纤溶系统的影响。方法急性动脉粥样硬化性脑梗死患者96例为观察组,非脑血管病患者98例为对照组。观察组按治疗方法不同又分为阿司匹林组(ASP组)、低分子肝素组(LMH组)和PTAS组。以双抗夹心酶联免疫吸附法检测患者入院后第1天和第7天血浆血管性假血友病因子(vWF)、组织型纤溶酶原激活物(tPA)及其抑制物-1(PAI-1)水平。结果观察组第1天和第7天血浆tPA、PAI-1和vWF抗原水平均显著高于对照组;PTAS组第7天vWF显著高于ASP组和LMH组,三指标水平均较第1天升高,且tPA,vWF的升高幅度显著大于、PAI-1水平增加则显著小于ASP组和LMH组。结论PTAS联合抗凝及抗血小板治疗在维持急性动脉粥样硬化性脑梗死患者体内纤溶活性方面不差于甚至可能优于单纯抗凝或抗血小板治疗。
出处 《广东医学》 CAS CSCD 北大核心 2009年第4期540-542,共3页 Guangdong Medical Journal
基金 广东省科技计划项目(编号:2008B030301346)
  • 相关文献

参考文献11

二级参考文献38

  • 1Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 2[1]Fitzgerald DJ. Vascular biology of thrombosis: the role of platelet-vessel wall adhesion. Neurology,2001,57 ( 5 Suppl 2 ): S1 ~ 4.
  • 3[2]Folsom AR, Rosamond WD,Shahar E,et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation,1999,100:736 ~ 742.
  • 4[3]Chia S, Ludlam CA, Fox KA, et al. Acute systemic inflammation ehhances endothelium-dependent tissue plasminogen activator release in men. J Am Coil Cardiol,2003,41:333 ~ 339.
  • 5[4]Lip GY, Blann AD, Farooqi IS, et al. Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients:the West Birmingham Stroke Project.Blood Coagul Fibrinolysis,2001, 12:307 ~ 315.
  • 6[5]Lazurova I, Kramer HJ. Endothelins-physiology, pathophysiology and importance in arterial hypertension. Vnitr Lek ,2000,46:719 ~ 723.
  • 7Duke RJ, Bloch RF, Turpie AG, et al. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med, 1986,105:825-828.
  • 8The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet,1997, 349:1569-1581.
  • 9Kay R, Wong KS, Yu YL, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med,1995,333:1588-1593.
  • 10Lu CZ. Low-molecular weight heparin for the treatment of acute ischemic stroke: a randomized controlled trial. HKMJ,2001,7(suppl):9-10.

共引文献33150

同被引文献35

  • 1王拥军.低分子量肝素在脑血管疾病中应用的专家共识[J].中华内科杂志,2005,44(11):874-875. 被引量:18
  • 2秦颖,马丽媛,倪金霞,唐强,朱文增,王德生.康复训练对急性脑梗死大鼠行为学及神经生长因子及脑源性神经营养因子的影响[J].中国临床康复,2006,10(24):85-87. 被引量:8
  • 3赵永波.老年脑梗死的治疗进展[J].实用老年医学,2006,20(4):226-228. 被引量:1
  • 4Cooney MT, Dudina AL, O' callaghan P, et al. yon WiUebrand factor in CHD and stroke: relationships and therapeutic implica- tions [J]. Curr Treat Options Cardiovasc Med, 2007, 9 (3) : 180-190.
  • 5Jangw J, Du B, Leung TW, et al. Symptomatic intraeranial steno- sis cerebrovascular complications from clective stent placement [J ]. Radiology., 2007, 243 (1): 188-197.
  • 6Yasuyuki O,Yoshiki T, Kazuhiro H, et al. Metabolic syndrome is a risk factor for acute cerebral infarction in a younger elderly kurashiki population[ J]. J Str Cereb Dis,2012,21 (3) :231 - 239.
  • 7Burhan T, Nilda T,Yahya C,et al. Differences in platelet-leukocyte aggregates among subtypes of acute cerebral ischemia [ J ]. J Neu Sci,2011,305 ( 1/2 ) : 126 - 130.
  • 8Kee OL, Won JK, Sang JN, et al. Clinical significance of anti-annex- in V antibody in acute cerebral ischemia[J]. J Neu Sci,2011,305 (1/2) :53 -56.
  • 9Cooney MT, Dudina AL, O' callaghan P, et al. von Willebrand factor in CHD and stroke:relationships and therapeutic implications [ J ]. Curr Treat Opt Card Med,2007,9(3) :180- 190.
  • 10Jangw J, Du B, Leung TW, et al. Symptomatic intracranial stenosis cerebrovascular complications from clective stent placement [ J ]. Radiology ,2007,243 ( 1 ) : 188 - 197.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部